Iterum Therapeutics Plc (ITRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 8,530 | 7,926 | 7,034 | 8,050 | 7,373 |
| Operating Income | -8,530 | -7,926 | -7,034 | -8,050 | -7,373 |
| Interest Expense | 399 | -80 | 636 | 766 | 1,039 |
| Other Income | -837 | 2,857 | -22,009 | 2,424 | 5,339 |
| Pre-tax Income | -9,766 | -4,989 | -29,679 | -6,392 | -3,073 |
| Income Tax | 123 | 101 | -570 | 343 | 427 |
| Net Income Continuous | -9,889 | -5,090 | -29,109 | -6,735 | -3,500 |
| Net Income | $-9,889 | $-5,090 | $-29,109 | $-6,735 | $-3,500 |
| EPS Basic Total Ops | -0.78 | -0.41 | -2.38 | -0.55 | -0.29 |
| EPS Basic Continuous Ops | -0.78 | -0.41 | -2.38 | -0.55 | -0.29 |
| EPS Diluted Total Ops | -0.78 | -0.41 | -2.38 | -0.55 | -0.29 |
| EPS Diluted Continuous Ops | -0.78 | -0.41 | -2.38 | -0.55 | -0.29 |
| EBITDA(a) | $-7,516 | $-6,897 | $-5,995 | $-7,010 | $-6,343 |